KalVista Pharmaceuticals Inc (KALV)
11.67
+0.42
(+3.73%)
USD |
NASDAQ |
May 31, 16:00
11.68
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Enterprise Value: 416.75M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 416.75M |
| May 30, 2024 | 399.03M |
| May 29, 2024 | 394.81M |
| May 28, 2024 | 391.86M |
| May 24, 2024 | 401.14M |
| May 23, 2024 | 400.72M |
| May 22, 2024 | 417.60M |
| May 21, 2024 | 414.22M |
| May 20, 2024 | 425.61M |
| May 17, 2024 | 427.30M |
| May 16, 2024 | 433.63M |
| May 15, 2024 | 431.10M |
| May 14, 2024 | 451.35M |
| May 13, 2024 | 430.67M |
| May 10, 2024 | 434.05M |
| May 09, 2024 | 434.47M |
| May 08, 2024 | 433.20M |
| May 07, 2024 | 438.69M |
| May 06, 2024 | 436.58M |
| May 03, 2024 | 436.16M |
| May 02, 2024 | 437.85M |
| May 01, 2024 | 438.27M |
| April 30, 2024 | 403.25M |
| April 29, 2024 | 388.91M |
| April 26, 2024 | 379.20M |
| Date | Value |
|---|---|
| April 25, 2024 | 366.97M |
| April 24, 2024 | 361.06M |
| April 23, 2024 | 397.34M |
| April 22, 2024 | 407.05M |
| April 19, 2024 | 412.53M |
| April 18, 2024 | 409.58M |
| April 17, 2024 | 415.91M |
| April 16, 2024 | 425.61M |
| April 15, 2024 | 419.70M |
| April 12, 2024 | 426.03M |
| April 11, 2024 | 434.89M |
| April 10, 2024 | 427.72M |
| April 09, 2024 | 422.66M |
| April 08, 2024 | 390.17M |
| April 05, 2024 | 392.28M |
| April 04, 2024 | 397.34M |
| April 03, 2024 | 399.45M |
| April 02, 2024 | 390.17M |
| April 01, 2024 | 405.36M |
| March 28, 2024 | 424.77M |
| March 27, 2024 | 391.44M |
| March 26, 2024 | 393.13M |
| March 25, 2024 | 393.97M |
| March 22, 2024 | 424.35M |
| March 21, 2024 | 437.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-38.75M
Minimum
Oct 19 2022
968.61M
Maximum
Feb 16 2021
215.71M
Average
187.47M
Median
Feb 13 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Myomo Inc | 87.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.03M |
| Total Expenses (Quarterly) | 33.15M |
| EPS Diluted (Quarterly) | -0.84 |
| Earnings Yield | -26.99% |
| Normalized Earnings Yield | -13.87 |